CYCLOBENZAPRINE HYDROCHLORIDE
NDC 52817-331, cyclobenzaprine hydrochloride, tablet, film coated, from TruPharma LLC.
- Product NDC
- 52817-331
- Status
- Listed
- Labeler
- TruPharma LLC
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208170
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/52817-331 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CYCLOBENZAPRINE HYDROCHLORIDE7.5 mg/1
Pharmacologic classes
Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 52817-331-10 | 52817033110 | 100 TABLET, FILM COATED in 1 BOTTLE (52817-331-10) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/08adc97f-feef-46fb-ac75-f015b4f3a43a
Use it
Look up 52817-331 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/52817-331 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 52817-331. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.